
About a year after the European Union became the first entity to propose regulations governing the use of artificial intelligence, Canada is following in its footsteps by proposing its own first-ever private sector regulation of AI.
Similarities between the two regulations reveal the influence, and the pressure, that the EU’s own AI approach is having on other jurisdictions looking to rein in an industry that had been left unchecked.
This June, the Canadian government introduced Bill C-27. If passed, the bill would not only reform federal private-sector privacy law but also regulate artificial intelligence under a new Artificial Intelligence and Data Act (AIDA).
To be sure, the Canadian and the European Union bills are still both in draft mode. But if the European Union passes its bill, it will create a pressure for other countries to pass their own—starting with Canada.
“With the EU AI regulation, we’re going to see a greater spotlight being shone on [AI-related] harms, because if it passes, which I think it will, we’re going to start seeing more regulatory action, more enforcement and action being taken against people in the AI industry,” said Justin P’ng, an associate in Canada’s law firm Fasken’s privacy and cybersecurity group. “There’s going to be that greater spotlight on it. And I think that’s going to put more pressure on other jurisdictions to act, to regulate something that has not been regulated historically or recently.”
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas